Data

Pharmaceutical industry payments to Australian healthcare professionals (October 2015 to October 2018)

The University of Sydney
Dr Barbara Mintzes (Aggregated by, Principal investigator) Dr Emily Karanges (Principal investigator, Aggregated by) Professor Lisa Bero (Aggregated by, Principal investigator)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doidoi.org/10.25910/5d6710d1d3d20&rft.title=Pharmaceutical industry payments to Australian healthcare professionals (October 2015 to October 2018)&rft.identifier=http://hdl.handle.net/2123/20945&rft.publisher=The University of Sydney&rft.description=About the project This project stems from the Evidence, Policy and Influence Collaborative, led by Prof Lisa Bero, which seeks to translate rigorous and unbiased evidence into clinical practice and health policy. One facet of this Collaborative is the study of bias in healthcare: we sought to understand the extent of pharmaceutical industry marketing in the form of payments to health professionals as a means to begin tracing the influence of marketing on clinical care.   About the Dataset The dataset contains pharmaceutical company reports of payments to Australian healthcare professionals for theprovision of services or sponsorship of medical education, including airfares, accommodation and registration fees. Itcollates 200 publicly available reports submitted to Medicines Australia by 35 companies between 1 October 2015and 31 October 2018.&rft.creator=Dr Barbara Mintzes&rft.creator=Dr Emily Karanges&rft.creator=Professor Lisa Bero&rft.date=2019&rft_rights=Open Access&rft_rights=CC BY-NC-SA: Attribution-Noncommercial-Share Alike 4.0 https://creativecommons.org/licenses/by-nc-sa/4.0/&rft_subject=PUBLIC HEALTH AND HEALTH SERVICES&rft_subject=MEDICAL AND HEALTH SCIENCES&rft_subject=Medical and Health Sciences not elsewhere classified&rft_subject=OTHER MEDICAL AND HEALTH SCIENCES&rft_subject=Pharmaceutical industry&rft_subject=Payments&rft_subject=Conflicts of Interest&rft_subject=Transparency&rft_subject=Healthcare Professionals&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Licence & Rights:

Non-Commercial Licence view details
CC-BY-NC-SA

CC BY-NC-SA: Attribution-Noncommercial-Share Alike 4.0
https://creativecommons.org/licenses/by-nc-sa/4.0/

Open Access

Access:

Other view details

Open Access

Full description

About the project
This project stems from the Evidence, Policy and Influence Collaborative, led by Prof Lisa Bero, which seeks to translate rigorous and unbiased evidence into clinical practice and health policy. One facet of this Collaborative is the study of bias in healthcare: we sought to understand the extent of pharmaceutical industry marketing in the form of payments to health professionals as a means to begin tracing the influence of marketing on clinical care.

 

About the Dataset

The dataset contains pharmaceutical company reports of payments to Australian healthcare professionals for the
provision of services or sponsorship of medical education, including airfares, accommodation and registration fees. It
collates 200 publicly available reports submitted to Medicines Australia by 35 companies between 1 October 2015
and 31 October 2018.

Issued: 29 08 2019

Data time period: 01 10 2015 to 31 10 2018

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Data

Related People

Related Grants and Projects

Subjects
Conflicts of Interest | Healthcare Professionals | Medical and Health Sciences | Medical and Health Sciences Not Elsewhere Classified | Other Medical and Health Sciences | Public Health and Health Services | Payments | Pharmaceutical industry | Transparency |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers
Similar data you may be interested in: